The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 16, 2021

Filed:

Sep. 20, 2016
Applicant:

Novartis Ag, Basel, CH;

Inventors:

Eric Aubin, Kembs, FR;

Anthony Casarez, San Francisco, CA (US);

Andreas Fisch, Basel, CH;

Zaixing Li, Shanghai, CN;

Mika Lindvall, Oakland, CA (US);

Heinz Ernst Moser, San Mateo, CA (US);

Michael Mutz, Lörrach, DE;

Folkert Reck, Walnut Creek, CA (US);

Bernd Ulrich Riebesehl, Loerrach, DE;

Marc Schoenhentz, Ungersheim, FR;

Vijay Sethuraman, Fremont, CA (US);

Robert Lowell Simmons, San Francsico, CA (US);

Assignee:

Novartis AG, Basel, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 417/14 (2006.01); A61P 31/04 (2006.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); A61P 31/04 (2018.01); C07B 2200/13 (2013.01);
Abstract

The invention provides new solid forms, salts and polymorphs of 1-(((Z)-(1-(2-aminothiazol-4-yl)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxooxazolidin-3-yl)methyl)-1-sulfoazetidin-3-yl)amino)ethylidene)amino)oxy)cyclopropanecarboxylic acid (referred to herein as Compound X), pharmaceutical compositions containing them, and processes for their manufacture and use in therapy.


Find Patent Forward Citations

Loading…